Stifel Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $20
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX) and Elanco Animal Health (ELAN)
Elanco Animal Health (NYSE:ELAN Shareholders Incur Further Losses as Stock Declines 6.8% This Week, Taking Three-year Losses to 58%
Morgan Stanley Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Maintains Target Price $15
Morgan Stanley analyst Erin Wright maintains $Elanco Animal Health(ELAN.US)$ with a hold rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 66.
Barclays Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Raises Target Price to $22
Barclays analyst Balaji Prasad maintains $Elanco Animal Health(ELAN.US)$ with a buy rating, and adjusts the target price from $21 to $22.According to TipRanks data, the analyst has a success rate of 4
Elanco Animal Health Shares Are Trading Lower After a William Blair Analyst Highlighted Concerns About Efficacy and Label Warnings With Its Itchy Dogs Dermatology Treatment.